title: Mycobacterium lentiflavum, an emerging pathogen?
abstract: Three cases of infection due to Mycobacterium lentiflavum, a recently described species characterized by multiple resistance to anti-mycobacterial drugs, are reported here. While one case simply adds to the number of cervical lynphadenitis reported in literature, the others concern the first isolations from pleural effusions, in a young boy with leukaemia and in an elderly patient with lung disease, respectively.
authors.affiliation: Microbiology and Virology Laboratory, Regional Reference Center for Mycobacteria, Careggi Hospital, 50134 Florence, Italy. e.tortoli@libero.it
authors.forename: Enrico
authors.initials: E
authors.lastname: Tortoli
authors.forename: Romano
authors.initials: R
authors.lastname: Mattei
authors.forename: Cristina
authors.initials: C
authors.lastname: Russo
authors.forename: Claudio
authors.initials: C
authors.lastname: Scarparo
mesh_terms: D000293:Adolescent; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D021821:Communicable Diseases, Emerging / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D016867:Immunocompromised Host; D007223:Infant; D007938:Leukemia / Q000150:complications*; D008199:Lymphadenitis / Q000382:microbiology*; D008297:Male; D009161:Mycobacterium / Q000145:classification / Q000302:isolation & purification / Q000472:pathogenicity*; D009164:Mycobacterium Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D010994:Pleura / Q000382:microbiology; D010996:Pleural Effusion / Q000209:etiology / Q000382:microbiology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents